Deliberations on the Ethical Use of Antipsychotic Medications in Children

Deliberations on the Ethical Use of Antipsychotic Medications in Children
A Peter Wall Institute for Advanced Studies
September 19-20, 2013
Cecil Green Park House, UBC
6251 Cecil Green Park Road, Vancouver, BC, V6T 1Z1

Prescriptions for second generation antipsychotic drugs (SGAs) to Canadian children and adolescents with mental health disorders have skyrocketed in the past 10 years. From 2005 to 2009, their use to treat a variety of mental health disorders, including attention deficit hyperactivity disorder, conduct disorder, and mood disorders increased by 114%. Currently, over 6000 children in the province of British Columbia alone are believed to be taking antipsychotic medications. Despite the rapid growth rate, none of these medications have been adequately studied in children for safety or efficacy, and none have been approved by Health Canada for use in this population.

This workshop is designed to bring together leading UBC and international experts to examine the ethical controversies surrounding recent increases in the off-label use of antipsychotic medications to treat mental health disorders in Canadian children. Clinicians, researchers, ethicists and advocates from a variety of disciplinary backgrounds will identify ethical concerns, gaps in our knowledge, and strategize on how to move forward to address challenges.

“Drug Harm in Children: How can we work together to prevent adverse drug reactions?”
Keynote Address by Dr. Bruce Carleton

Stakeholder perspectives panel discussion (Parents, Clinicians, Ethicists, and Researchers)

September 19, 2013
Michael Smith Labs, UBC
Lecture Theatre, Room 102
2185 East Mall, Vancouver, BC
For details, please click here.